Tetraaryldimethoxybenziporphyrins
br s); 1H NMR (TFA-CDCl3; 30 °C): δ 1.46 (18H, s), 3.36 (1H,
s), 3.48 (6H, s), 6.56 (1H, s), 6.59 (1H, br s), 7.22 (2H, dd, J )
1.6, 5.2 Hz), 7.55 (2H, d, J ) 1.2 Hz), 7.60-7.73 (16H, m), 7.85-
7.90 (6H, m), 8.26 (2H, br s); 13C NMR (CDCl3): δ 31.7, 34.8,
55.6, 98.4, 109.8, 114.5, 122.1, 124.8, 127.3, 127.7, 129.7, 130.8,
131.6, 132.4, 135.2, 137.3, 142.0, 143.6, 147.3, 150.3, 156.6, 160.0,
170.6; 13C NMR (TFA-CDCl3): δ 31.4, 35.2, 56.3, 95.7, 99.8,
116.3, 122.3, 126.1, 128.7, 129.0, 132.0, 132.9, 133.6, 134.0, 136.6,
139.9, 144.1, 146.7, 150.1, 154.2, 158.7, 163.9; HR FAB MS:
Calcd for C56H51N3O2 + H: 798.4059. Found: 798.4071. Anal.
Calcd for C56H51N3O2·1/10CHCl3: C, 83.19; H, 6.36; N, 5.19.
Found: C, 83.01; H, 6.13; N, 5.08.
toluene (0.700 g; 1.92 mmol), pyrrole (410 µL; 5.9 mmol),
benzaldehyde (405 µL; 4.0 mmol), boron trifluoride etherate
(200 µL), and DDQ (1.40 g). The crude product was purified on
Grade 3 basic alumina eluting with dichloromethane, and following
a forerun of tetraphenylporphyrin and unidentified brown byprod-
ucts, 12a was collected as a dark emerald green band. The porphyrin
analogue was rechromatographed on Grade 3 basic alumina, eluting
with dichloromethane, and the product fraction recrystallized from
chloroform-methanol to give benziporphyrin 12a (340 mg;
0.486 mmol; 25%) as a navy-blue powder, mp 286-288 °C. In
some batches, the product was obtained as lustrous dark blue-green
flakes. UV-vis (1% Et3N-CHCl3): λmax (logꢀ) 321 (4.50), 368
(4.40), 422 (4.82), 699 nm (4.17); UV-vis (1% TFA-CHCl3): λmax
(logꢀ) 324 (4.44), 404 (sh, 4.56), 472 (4.90), 658 (3.72), 889 nm
2,4-Dimethoxy-11,16-bis(4-methylphenyl)-6,21-diphenylben-
ziporphyrin (11c). The tetraarylporphyrinoid was prepared by the
earlier procedure from dicarbinol 13a (0.700 g; 2.00 mmol), pyrrole
(415 µL; 6.0 mmol), p-tolualdehyde (0.480 g; 4.0 mmol), and
200 µL of BF3‚Et2O. Recrystallization from chloroform-methanol
gave 11c (0.22 g; 0.31 mmol; 15%) as bright green crystals, mp
278-279 °C; UV-vis (1% Et3N-CHCl3): λmax (logꢀ) 326 (4.53),
355 (4.55), 440 (4.74), 670 (sh, 4.16), 707 nm (4.23); UV-vis (1%
TFA-CHCl3): λmax (logꢀ) 325 (4.42), 416 (4.71), 493 (4.77), 673
1
(4.29); H NMR (CDCl3): δ 2.01 (3H, s), 3.27 (6H, s), 6.42 (1H,
s), 6.51 (2H, d, J ) 4.8 Hz), 6.77 (2H, s), 7.38-7.48 (14H, m),
1
7.54-7.58 (8H, m), 9.93 (1H, br s); H NMR (TFA-CDCl3): δ
2.03 (3H, s), 3.19 (6H, s), 4.73 (1H, s), 7.07 (2H, dd, J ) 4.8,
0.8 Hz), 7.33 (2H, s), 7.54-7.64 (10H, m), 7.68-7.76 (10H, m),
7.87 (2H, dd, J ) 5.2, 1.2 Hz), 8.21 (1H, br s), 9.96 (2H, br s); 13
C
NMR (CDCl3): δ 10.4, 61.4, 107.7, 114.7, 127.0, 127.5, 127.8,
128.1, 128.5, 129.3, 131.1, 131.3, 132.5, 135.4, 140.0, 142.7, 142.8,
147.8, 157.2, 158.0, 171.3; 13C NMR (TFA-CDCl3): δ 11.1, 62.7,
92.6, 116.4, 128.6, 129.1, 129.2, 129.4, 130.0, 130.5, 132.5, 132.9,
133.6, 136.3, 137.7, 139.7, 144.7, 148.7, 151.7, 161.1, 162.3; EI
MS (70 eV): m/z (% rel int) 704.4 (9), 703.4 (27), 702.4 (53),
701.4 (100), 700.4 (17), 699.4 (26, M+), 350.9 (26), 349.9 (7.6,
1
(3.89), 888 nm (4.39); H NMR (CDCl3): δ 2.44 (6H, s), 3.37
(6H, s), 5.84 (1H, s), 6.40 (1H, s), 6.58 (2H, d, J ) 4.4 Hz), 6.89
(2H, s), 7.24 (4H, d, J ) 8 Hz), 7.36-7.45 (12H, m), 7.58 (4H, d,
J ) 7 Hz), 9.24 (1H, br s); 1H NMR (TFA-CDCl3): δ 2.55 (6H,
s), 3.27 (1H, s), 3.48 (6H, s), 6.34 (1H, br s), 6.57 (1H, s), 7.20
(2H, dd, J ) 1.2, 5.2 Hz), 7.45 (4H, d, J ) 8 Hz), 7.52 (2H, d, J
) 1.2 Hz), 7.56 (4H, d, J ) 8 Hz), 7.66-7.73 (6H, m), 7.85-7.89
(4H, m), 7.90 (2H, dd, J ) 1.4, 5.0 Hz), 8.17 (2H, br s); 13C NMR
(CDCl3): δ 21.4, 55.6, 98.5, 109.7, 114.4, 122.1, 127.3, 127.7,
128.7, 129.6, 130.7, 131.6, 132.6, 135.3, 137.0, 137.3, 142.1, 143.6,
147.3, 156.6, 159.7, 170.5; 13C NMR (TFA-CDCl3): δ 21.5, 56.3,
95.9, 99.8, 116.2, 122.4, 128.5, 128.9, 129.8, 131.9, 132.8, 133.5,
134.0, 136.6, 140.0, 141.0, 144.1, 146.6, 150.3, 158.8, 163.9; EI
MS (70 eV): m/z (% rel int) 719 (1.8), 718 (3.9), 717 (8.9), 716
(10), 715 (18), 358 (3.4), 91 (100); HR EI MS: Calcd for
C50H39N3O2 + 2H: 715.3199. Found: 715.3202. Anal. Calcd for
C50H39N3O2·1/3CHCl3: C, 80.21; H, 5.26; N, 5.57. Found: C, 79.88;
H, 5.17; N, 5.53.
M
2+), 91.0 (81); HR MS: Calcd for C49H37N3O2 + 2H: 701.3042.
Found: 701.3041. Anal. Calcd for C49H37N3O2‚0.4CHCl3: C, 79.37;
H, 5.04; N, 5.62. Found: C, 79.62; H, 5.02; N, 5.81.
2,4-Dimethoxy-3-methyl-11,16-bis(4-tert-butylphenyl)-6,21-
diphenylbenziporphyrin (12b). The porphyrin analogue was
prepared similarly from dicarbinol 13b (0.700 g; 1.92 mmol),
pyrrole (410 µL; 5.9 mmol), 4-tert-butylbenzaldehyde (0.65 g;
4.0 mmol), and 200 µL of BF3‚Et2O. Recrystallization from
chloroform-methanol gave 12b (0.32 g; 0.40 mmol; 21%) as
lustrous navy blue crystals, mp 260-262 °C; UV-vis (1% Et3N-
CHCl3): λmax (logꢀ) 424 (4.83), 712 nm (4.19); UV-vis (1% TFA-
CHCl3): λmax (logꢀ) 343 (4.47), 411 (sh, 4.61), 477 (4.92), 670
1
(3.80), 900 nm (4.24); H NMR (CDCl3): δ 1.39 (18H, s), 2.01
2,4-Dimethoxy-11,16-bis(4-chlorophenyl)-6,21-diphenylben-
ziporphyrin (11d). The benziporphyrin was prepared by the
foregoing procedure from dicarbinol 13a (1.40 g; 4.00 mmol),
pyrrole (830 µL; 6.0 mmol), 4-chlorobenzaldehyde (1.12 g;
8.0 mmol), and 400 µL of BF3‚Et2O in chloroform (900 mL).
Recrystallization from chloroform-methanol gave 11d (0.58 g;
0.77 mmol; 19%) as dark green crystals, mp 277-278 °C; UV-
vis (1% Et3N-CHCl3): λmax (logꢀ) 357 (4.59), 438 (4.72), 661
(sh, 4.17), 697 nm (4.23); UV-vis (1% TFA-CHCl3): λmax (logꢀ)
322 (4.49), 411 (4.73), 493 (4.77), 601 (3.89), 663 (3.89), 871 nm
(3H, s), 3.27 (6H, s), 6.42 (1H, s), 6.54 (2H, d, J ) 4.8 Hz), 6.82
(2H, s), 7.36 (4H, d, J ) 7.6 Hz), 7.38 (2H, d, J ) 4.4 Hz), 7.42-
7.48 (10H, m), 7.53-7.58 (4H, m), 9.94 (1H, br s); 1H NMR
(TFA-CDCl3): δ 1.43 (18H, s), 2.03 (3H, s), 3.21 (6H, s), 4.68
(1H, s), 7.11 (2H, dd, J ) 1.6, 5.2 Hz), 7.36 (2H, d, J ) 1.6 Hz),
7.48 (4H, d, J ) 8.4 Hz), 7.60 (4H, d, J ) 8.4 Hz), 7.66-7.75
(10H, m), 7.85 (2H, dd, J ) 1.2, 5.2 Hz), 8.22 (1H, br s), 9.92
(2H, br s); 13C NMR (CDCl3): δ 10.3, 31.6, 34.8, 61.3, 107.5,
114.6, 124.9, 126.9, 127.7, 128.3, 129.3, 130.0, 131.3, 131.4, 132.1,
135.2, 137.0, 142.4, 142.8, 147.8, 150.4, 157.2, 157.9, 171.5; 13C
NMR (TFA-CDCl3): δ 11.1, 31.4, 35.2, 62.7, 91.3, 116.7, 126.1,
128.7, 129.1, 129.7, 130.0, 132.4, 132.9, 133.5, 137.4, 139.8, 144.7,
147.9, 151.5, 154.3, 161.0, 162.1; FAB MS: m/z (% rel int) 816
(3.9), 815 (14), 814 (40), 813 (85), 812 (100), 811 (7.2, M+), 810
(3.9); HR FAB MS: Calcd for C57H53N3O2 + H: 812.4216.
Found: 812.4202. Anal. Calcd for C57H53N3O2: C, 84.31; H, 6.58;
N, 5.17. Found: C, 83.81; H, 6.45; N, 5.27.
1
(4.42); H NMR (CDCl3; 30 °C): δ 3.37 (6H, s), 5.82 (1H, s),
6.39 (1H, s), 6.55 (2H, d, J ) 4.8 Hz), 6.86 (2H, s), 7.40-7.47
1
(16H, m), 7.56-7.60 (4H, m), 9.22 (1H, br s); H NMR (TFA-
CDCl3): δ 3.45 (1H, s), 3.49 (6H, s), 6.56 (1H, s), 6.71 (1H, s),
7.17 (2H, dd, J ) 1.6, 5.2 Hz), 7.49 (2H, d, J ) 1.6 Hz), 7.60-
7.64 (8H, m), 7.66-7.76 (6H, m), 7.84-7.87 (4H, m), 7.89 (2H,
dd, J ) 2.0, 5.2 Hz), 8.34 (2H, br s); 13C NMR (CDCl3): δ 55.6,
98.4, 110.4, 113.3, 122.0, 127.4, 127.9, 128.3, 129.6, 130.1, 131.6,
133.6, 133.9, 135.7, 138.7, 143.2, 143.4, 147.1, 156.5, 160.0, 169.8;
13C NMR (TFA-CDCl3): δ 56.3, 97.9, 99.6, 114.6, 122.4, 128.0,
128.9, 129.4, 132.1, 132.7, 133.6, 135.1, 135.3, 136.8, 137.1, 139.9,
144.1, 147.7, 150.4, 158.5, 164.1; EI MS (70 eV): m/z (% rel int)
760 (1.6), 759 (3.7), 758 (4.7), 757 (9.5), 756 (5.9), 755 (10), 377
(2.0), 91 (100); HR EI MS: Calcd for C48H33Cl2N3O2 + 2H:
755.2106. Found: 755.2088. Anal. Calcd for C48H33Cl2N3O2‚1/3-
CHCl3: C, 73.07; H, 4.23; N, 5.29. Found: C, 73.05; H, 4.09; N,
5.16.
2,4-Dimethoxy-3-methyl-11,16-bis(4-methylphenyl)-6,21-di-
phenylbenziporphyrin (12c). Porphyrinoid 12c was prepared from
dicarbinol 13b (0.700 g; 1.92 mmol), pyrrole (420 µL; 6.0 mmol),
p-tolualdehyde (0.480 g; 4.00 mmol), and 200 µL of BF3‚Et2O.
Recrystallization from chloroform-methanol gave 6c (267 mg;
0.367 mmol; 19%) as small shiny purple needles, mp 280-281
°C; UV-vis (1% Et3N-CHCl3): λmax (logꢀ) 425 (4.81), 712 nm
(4.16); UV-vis (1% TFA-CHCl3): λmax (logꢀ) 328 (4.44), 410
(sh, 4.58), 477 (4.90), 673 (3.76), 900 nm (4.22); 1H NMR
(CDCl3): δ 2.01 (3H, s), 2.43 (6H, s), 3.27 (6H, s), 6.41 (1H, s),
6.52 (2H, d, J ) 4.4 Hz), 6.77 (2H, s), 7.22 (4H, d, J ) 8.4 Hz),
7.32 (2H, d, J ) 8.0 Hz), 7.38 (2H, d, J ) 4.4 Hz), 7.41-7.48
2,4-Dimethoxy-3-methyl-6,11,16,21-tetraphenylbenziporphy-
rin (12a). The porphyrin analogue was prepared by the foregoing
procedure from 3,5-bis(R-hydroxyphenylmethyl)-2,6-dimethoxy-
J. Org. Chem, Vol. 72, No. 17, 2007 6489